CAR T-Cell Therapy Market

CAR T-Cell Therapy Market Size, Share, Growth Analysis, By Drug Type(Axicabtagene Ciloleucel, Tisagenlecleucel), By Indication(Lymphoma, Acute Lymphocytic Leukemia), By End User(Hospitals, Cancer Treatment Centers), By Geography(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35H2222 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

CAR T-Cell Therapy Market Insights

Market Overview:

CAR T-cell therapy has emerged as a transformative force within the healthcare sector, with the global market size reaching USD 2.19 billion in 2022 and poised for remarkable growth. Forecasts suggest that the market will witness a substantial expansion to approximately USD 6.43 billion by 2032, driven by a noteworthy compound annual growth rate (CAGR) of 11.37% from 2023 to 2032. This exponential growth trajectory is primarily attributed to the rising prevalence of cancer and the increasing adoption of innovative immunotherapies like CAR T-cell therapy. As personalized medicine gains traction, the therapeutic potential of engineered T-cells to effectively target and treat malignancies continues to captivate both patients and healthcare stakeholders. The promising outlook of the CAR T-cell therapy market underscores its pivotal role in reshaping the landscape of cancer treatment, paving the way for improved patient outcomes and a more optimistic future in oncology.

CAR T-Cell Therapy Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for CAR T-Cell Therapy was estimated to be valued at US$ XX Mn in 2021.

The global CAR T-Cell Therapy Market is estimated to grow at a CAGR of XX% by 2028.

The global CAR T-Cell Therapy Market is segmented on the basis of Drug Type, Indication, End User, Geography.

Based on region, the global CAR T-Cell Therapy Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global CAR T-Cell Therapy Market are Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., MEDIPOST, PHARMICELL Co., Ltd., ANTEROGEN. CO., LTD, Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc., Curocell, Inc., JW Therapeutics (Shanghai) Co., Ltd., Stempeutics Research PVT LTD.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

CAR T-Cell Therapy Market

Product ID: UCMIG35H2222

$5,300
BUY NOW GET FREE SAMPLE